Your browser doesn't support javascript.
loading
Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications.
Ruscitti, Piero; Di Cola, Ilenia; Di Muzio, Claudia; Italiano, Noemi; Ursini, Francesco; Giacomelli, Roberto; Cipriani, Paola.
Afiliação
  • Ruscitti P; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. Electronic address: piero.ruscitti@univaq.it.
  • Di Cola I; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Di Muzio C; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Italiano N; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Ursini F; Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy; Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
  • Giacomelli R; Rheumatology and Immunology Unit, Department of Medicine, University of Rome Campus Biomedico, Rome, Italy.
  • Cipriani P; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Autoimmun Rev ; 21(7): 103114, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35595050

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Still de Início Tardio / Síndrome de Ativação Macrofágica / Hiperferritinemia / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Still de Início Tardio / Síndrome de Ativação Macrofágica / Hiperferritinemia / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article